Mettler-Toledo International Inc. (NYSE:MTD) Shares Purchased by iA Global Asset Management Inc.

iA Global Asset Management Inc. increased its position in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 40.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,199 shares of the medical instruments supplier's stock after buying an additional 347 shares during the quarter. iA Global Asset Management Inc.'s holdings in Mettler-Toledo International were worth $1,467,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. raised its stake in shares of Mettler-Toledo International by 14.7% during the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock valued at $332,634,000 after acquiring an additional 28,478 shares during the last quarter. M&T Bank Corp lifted its holdings in Mettler-Toledo International by 14.3% in the 3rd quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier's stock worth $7,387,000 after buying an additional 615 shares during the period. Allworth Financial LP increased its stake in shares of Mettler-Toledo International by 367.4% during the fourth quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock valued at $285,000 after buying an additional 169 shares during the period. Nordea Investment Management AB raised its holdings in shares of Mettler-Toledo International by 29.8% during the fourth quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier's stock valued at $129,919,000 after acquiring an additional 24,285 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. boosted its holdings in Mettler-Toledo International by 18.0% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier's stock valued at $42,058,000 after acquiring an additional 5,234 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

Several research firms have weighed in on MTD. Wolfe Research started coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a "peer perform" rating on the stock. Robert W. Baird boosted their target price on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Evercore ISI increased their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research note on Monday, February 10th. Wells Fargo & Company boosted their price objective on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an "equal weight" rating in a research note on Monday, February 10th. Finally, Citigroup lowered their price target on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International currently has an average rating of "Hold" and a consensus price target of $1,380.50.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD traded down $10.39 during trading on Tuesday, hitting $1,201.67. The company had a trading volume of 18,747 shares, compared to its average volume of 127,553. The stock has a 50 day simple moving average of $1,291.57 and a 200 day simple moving average of $1,308.45. The firm has a market capitalization of $25.04 billion, a P/E ratio of 29.64, a price-to-earnings-growth ratio of 3.30 and a beta of 1.15. Mettler-Toledo International Inc. has a 12 month low of $1,142.91 and a 12 month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. As a group, analysts predict that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Insider Activity at Mettler-Toledo International

In related news, insider Christian Magloth sold 790 shares of the business's stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the transaction, the insider now owns 734 shares of the company's stock, valued at $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Gerry Keller sold 600 shares of Mettler-Toledo International stock in a transaction on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the transaction, the insider now owns 6 shares in the company, valued at $8,108.04. This represents a 99.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is owned by corporate insiders.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.